Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell and spatial transcriptomics reveal SPRR2A<sup>+</sup> epithelial-MMP1<sup>+</sup> fibroblast interactions as key drivers of Esophageal Squamous Cell Carcinoma progression.

International journal of biological macromolecules·2026
Same author

Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma.

Frontiers in immunology·2026
Same author

A novel immune-related gene signature stratifies prognosis and characterizes the tumor immune microenvironment in head and neck squamous cell carcinoma.

Frontiers in cell and developmental biology·2026
Same author

Identification of Trogocytosis as an Essential Limitation Factor in hPSC-derived CAR Macrophages.

International journal of biological sciences·2026
Same author

Investigation of the expression and potential mechanistic role of BYSL in acute myeloid leukemia.

Clinical and experimental medicine·2026
Same author

Integrated multi-platform metabolomics reveals fatty acid-mediated inflammatory signatures in pretibial myxedema.

Frontiers in endocrinology·2026

Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.3K

Microtransplantation for myeloid sarcoma: Two case reports.

Xue Zhang1, Shuoting Wang1, Fujue Wang1

  • 1Department of Hematology and Research Laboratory of Hematology, West China Hospital, Sichuan University, #37 Guoxue Alley, Wuhou District, Chengdu 610041, Sichuan, China.

Leukemia Research Reports
|May 31, 2022
PubMed
Summary
This summary is machine-generated.

Microtransplantation offers a low-toxicity alternative for myeloid sarcoma (MS) treatment, showing promising long-term survival in two patients. This approach may improve outcomes for rare extramedullary tumors.

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.3K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.1K

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.3K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.3K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.1K

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Myeloid sarcoma (MS) is a rare extramedullary tumor associated with poor prognosis and high recurrence rates.
  • Traditional transplantation methods have limitations, including HLA matching requirements and toxicity.
  • Microtransplantation, an alternative approach, offers lower toxicity and may preserve graft-versus-leukemia effects, showing promise in acute myeloid leukemia (AML).

Observation:

  • This report details two cases of myeloid sarcoma treated with microtransplantation.
  • The study explores the application of microtransplantation in a patient population where it has not been previously reported.

Findings:

  • Both patients treated with microtransplantation achieved significant disease-free survival.
  • One patient had 66 months and the other 55 months of disease-free survival.

Implications:

  • Microtransplantation represents a potential novel therapeutic strategy for myeloid sarcoma.
  • These findings suggest microtransplantation could improve outcomes for patients with rare extramedullary tumors.
  • Further research is warranted to establish the efficacy and safety of microtransplantation for MS.